

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.20444046 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.20444046 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 3.97267378 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97267378 |
| 5 | lymphangiogenesis (GO:0001946) | 3.65222406 |
| 6 | chondrocyte proliferation (GO:0035988) | 3.47875715 |
| 7 | cell migration involved in heart development (GO:0060973) | 3.40411225 |
| 8 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.37400876 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 3.28290279 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 3.22356641 |
| 11 | negative regulation of fatty acid transport (GO:2000192) | 3.22230379 |
| 12 | skin morphogenesis (GO:0043589) | 3.21478123 |
| 13 | coronary vasculature morphogenesis (GO:0060977) | 3.05863730 |
| 14 | basement membrane organization (GO:0071711) | 3.04188514 |
| 15 | regulation of fibrinolysis (GO:0051917) | 3.01788954 |
| 16 | protein carboxylation (GO:0018214) | 3.01427674 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.01427674 |
| 18 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.00914994 |
| 19 | wound healing, spreading of epidermal cells (GO:0035313) | 2.95032575 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94670087 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 2.92577213 |
| 22 | cell-substrate junction assembly (GO:0007044) | 2.92054292 |
| 23 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.89759351 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87558339 |
| 25 | endothelial cell chemotaxis (GO:0035767) | 2.84324035 |
| 26 | regulation of protein activation cascade (GO:2000257) | 2.83239542 |
| 27 | endodermal cell differentiation (GO:0035987) | 2.82649744 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.82395481 |
| 29 | transcytosis (GO:0045056) | 2.79620210 |
| 30 | bile acid biosynthetic process (GO:0006699) | 2.78909055 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 2.78520353 |
| 32 | protein heterotrimerization (GO:0070208) | 2.78205401 |
| 33 | drug transmembrane transport (GO:0006855) | 2.77851386 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 2.77711380 |
| 35 | extracellular matrix assembly (GO:0085029) | 2.77669073 |
| 36 | hemidesmosome assembly (GO:0031581) | 2.76274046 |
| 37 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.75946554 |
| 38 | complement activation, alternative pathway (GO:0006957) | 2.75429557 |
| 39 | tyrosine metabolic process (GO:0006570) | 2.74399389 |
| 40 | COPII vesicle coating (GO:0048208) | 2.73828322 |
| 41 | regulation of complement activation (GO:0030449) | 2.72704795 |
| 42 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.72183287 |
| 43 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.71575930 |
| 44 | blood vessel maturation (GO:0001955) | 2.71356610 |
| 45 | sprouting angiogenesis (GO:0002040) | 2.69901952 |
| 46 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.69365669 |
| 47 | cardiac myofibril assembly (GO:0055003) | 2.67965554 |
| 48 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.67172711 |
| 49 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.66591683 |
| 50 | glomerular basement membrane development (GO:0032836) | 2.66018634 |
| 51 | endocrine hormone secretion (GO:0060986) | 2.65187031 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 2.64650521 |
| 53 | peripheral nervous system axon ensheathment (GO:0032292) | 2.63233615 |
| 54 | myelination in peripheral nervous system (GO:0022011) | 2.63233615 |
| 55 | regulation of extracellular matrix disassembly (GO:0010715) | 2.61171533 |
| 56 | regulation of pigment cell differentiation (GO:0050932) | 2.61099787 |
| 57 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61099272 |
| 58 | substrate-dependent cell migration (GO:0006929) | 2.60583986 |
| 59 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58636361 |
| 60 | response to gravity (GO:0009629) | 2.57715083 |
| 61 | cysteine metabolic process (GO:0006534) | 2.55544554 |
| 62 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.54814795 |
| 63 | smooth muscle tissue development (GO:0048745) | 2.54548301 |
| 64 | triglyceride homeostasis (GO:0070328) | 2.54252562 |
| 65 | acylglycerol homeostasis (GO:0055090) | 2.54252562 |
| 66 | positive regulation of fibroblast migration (GO:0010763) | 2.53675968 |
| 67 | positive regulation of fatty acid oxidation (GO:0046321) | 2.51561618 |
| 68 | homocysteine metabolic process (GO:0050667) | 2.51358581 |
| 69 | kidney mesenchyme development (GO:0072074) | 2.50658066 |
| 70 | cell-substrate adherens junction assembly (GO:0007045) | 2.50479929 |
| 71 | focal adhesion assembly (GO:0048041) | 2.50479929 |
| 72 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49804446 |
| 73 | membrane raft organization (GO:0031579) | 2.49493863 |
| 74 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.48918642 |
| 75 | atrioventricular valve morphogenesis (GO:0003181) | 2.48508783 |
| 76 | coenzyme catabolic process (GO:0009109) | 2.48401489 |
| 77 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.48096163 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 2.47701068 |
| 79 | plasma membrane repair (GO:0001778) | 2.47432878 |
| 80 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.46925885 |
| 81 | venous blood vessel morphogenesis (GO:0048845) | 2.46472936 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 2.46277736 |
| 83 | glyoxylate metabolic process (GO:0046487) | 2.45784096 |
| 84 | hippo signaling (GO:0035329) | 2.45705486 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 2.45385180 |
| 86 | bile acid metabolic process (GO:0008206) | 2.44942664 |
| 87 | adherens junction assembly (GO:0034333) | 2.44883216 |
| 88 | exocrine pancreas development (GO:0031017) | 2.44240278 |
| 89 | fibrinolysis (GO:0042730) | 2.43736436 |
| 90 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.42469711 |
| 91 | ovulation from ovarian follicle (GO:0001542) | 2.41138927 |
| 92 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.39406067 |
| 93 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.38666301 |
| 94 | barbed-end actin filament capping (GO:0051016) | 2.38654805 |
| 95 | positive regulation of muscle hypertrophy (GO:0014742) | 2.37769808 |
| 96 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.37769808 |
| 97 | phospholipid homeostasis (GO:0055091) | 2.37333907 |
| 98 | macroautophagy (GO:0016236) | 2.37172037 |
| 99 | extracellular fibril organization (GO:0043206) | 2.36787878 |
| 100 | aromatic amino acid family metabolic process (GO:0009072) | 2.36528144 |
| 101 | negative regulation of digestive system process (GO:0060457) | 2.35992465 |
| 102 | protein retention in ER lumen (GO:0006621) | 2.35915516 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 2.35593065 |
| 104 | fatty acid transmembrane transport (GO:1902001) | 2.33910942 |
| 105 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.33814024 |
| 106 | endocardial cushion morphogenesis (GO:0003203) | 2.33480448 |
| 107 | metanephric mesenchyme development (GO:0072075) | 2.33092733 |
| 108 | lysine metabolic process (GO:0006553) | 2.33049788 |
| 109 | lysine catabolic process (GO:0006554) | 2.33049788 |
| 110 | fatty acid catabolic process (GO:0009062) | 2.33045932 |
| 111 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.32827796 |
| 112 | tryptophan metabolic process (GO:0006568) | 2.32278487 |
| 113 | indole-containing compound catabolic process (GO:0042436) | 2.31254889 |
| 114 | indolalkylamine catabolic process (GO:0046218) | 2.31254889 |
| 115 | tryptophan catabolic process (GO:0006569) | 2.31254889 |
| 116 | type B pancreatic cell development (GO:0003323) | 2.30913796 |
| 117 | protein localization to cell surface (GO:0034394) | 2.30800490 |
| 118 | fatty acid oxidation (GO:0019395) | 2.30596341 |
| 119 | high-density lipoprotein particle remodeling (GO:0034375) | 2.29881703 |
| 120 | endothelial cell morphogenesis (GO:0001886) | 2.29347492 |
| 121 | regulation of muscle hypertrophy (GO:0014743) | 2.29306596 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 2.29275454 |
| 123 | collagen fibril organization (GO:0030199) | 2.29004773 |
| 124 | negative regulation of anoikis (GO:2000811) | 2.28717192 |
| 125 | desmosome organization (GO:0002934) | 2.28629730 |
| 126 | heart trabecula formation (GO:0060347) | 2.28421282 |
| 127 | muscle cell cellular homeostasis (GO:0046716) | 2.28151702 |
| 128 | acetyl-CoA metabolic process (GO:0006084) | 2.27772227 |
| 129 | apoptotic cell clearance (GO:0043277) | 2.27584761 |
| 130 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.26414115 |
| 131 | lipid oxidation (GO:0034440) | 2.25895546 |
| 132 | type B pancreatic cell proliferation (GO:0044342) | 2.25837746 |
| 133 | positive regulation of p38MAPK cascade (GO:1900745) | 2.25822599 |
| 134 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.25820684 |
| 135 | kynurenine metabolic process (GO:0070189) | 2.25412695 |
| 136 | regulation of bile acid biosynthetic process (GO:0070857) | 2.24816706 |
| 137 | negative regulation of wound healing (GO:0061045) | 2.24314005 |
| 138 | myofibril assembly (GO:0030239) | 2.24120124 |
| 139 | fibroblast migration (GO:0010761) | 2.24005707 |
| 140 | regulation of triglyceride catabolic process (GO:0010896) | 2.23823729 |
| 141 | keratan sulfate catabolic process (GO:0042340) | 2.23820029 |
| 142 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.23762176 |
| 143 | wound healing, spreading of cells (GO:0044319) | 2.23505578 |
| 144 | regulation of p38MAPK cascade (GO:1900744) | 2.23134176 |
| 145 | protein localization to endosome (GO:0036010) | 2.22894643 |
| 146 | glomerular filtration (GO:0003094) | 2.22881501 |
| 147 | endothelium development (GO:0003158) | 2.22694885 |
| 148 | urea metabolic process (GO:0019627) | 2.22562773 |
| 149 | urea cycle (GO:0000050) | 2.22562773 |
| 150 | stress fiber assembly (GO:0043149) | 2.22400079 |
| 151 | collagen metabolic process (GO:0032963) | 2.22286971 |
| 152 | endocardial cushion development (GO:0003197) | 2.21796099 |
| 153 | negative regulation of lipase activity (GO:0060192) | 2.21281222 |
| 154 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.21083652 |
| 155 | reverse cholesterol transport (GO:0043691) | 2.20790251 |
| 156 | extracellular matrix organization (GO:0030198) | 2.20413354 |
| 157 | cell adhesion mediated by integrin (GO:0033627) | 2.20130801 |
| 158 | very long-chain fatty acid metabolic process (GO:0000038) | 2.19864242 |
| 159 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.19631638 |
| 160 | negative regulation of complement activation (GO:0045916) | 2.19579839 |
| 161 | extracellular structure organization (GO:0043062) | 2.19478088 |
| 162 | positive regulation of endothelial cell migration (GO:0010595) | 2.19432903 |
| 163 | regulation of the force of heart contraction (GO:0002026) | 2.19265257 |
| 164 | actin filament depolymerization (GO:0030042) | 2.19224605 |
| 165 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.19086578 |
| 166 | epoxygenase P450 pathway (GO:0019373) | 2.19033038 |
| 167 | cellular ketone body metabolic process (GO:0046950) | 2.18562819 |
| 168 | positive regulation of lipid catabolic process (GO:0050996) | 2.18488489 |
| 169 | bile acid and bile salt transport (GO:0015721) | 2.18455499 |
| 170 | amino-acid betaine metabolic process (GO:0006577) | 2.18432941 |
| 171 | growth hormone receptor signaling pathway (GO:0060396) | 2.18346495 |
| 172 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.17885785 |
| 173 | lung lobe morphogenesis (GO:0060463) | 2.17745582 |
| 174 | negative regulation of blood coagulation (GO:0030195) | 2.17031662 |
| 175 | negative regulation of hemostasis (GO:1900047) | 2.17031662 |
| 176 | actin-mediated cell contraction (GO:0070252) | 2.16939693 |
| 177 | regulation of plasminogen activation (GO:0010755) | 2.16234482 |
| 178 | extracellular matrix disassembly (GO:0022617) | 2.16137804 |
| 179 | monocarboxylic acid catabolic process (GO:0072329) | 2.16032852 |
| 180 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.15762336 |
| 181 | aspartate family amino acid catabolic process (GO:0009068) | 2.15529188 |
| 182 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.15302618 |
| 183 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.14924053 |
| 184 | cell-substrate adhesion (GO:0031589) | 2.14794171 |
| 185 | pericardium development (GO:0060039) | 2.14697153 |
| 186 | fatty acid elongation (GO:0030497) | 2.14477936 |
| 187 | cell-matrix adhesion (GO:0007160) | 2.13931264 |
| 188 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.13555984 |
| 189 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.13282021 |
| 190 | renal filtration (GO:0097205) | 2.13229307 |
| 191 | thioester biosynthetic process (GO:0035384) | 2.12891472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.99742701 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.97088682 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92195711 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79774783 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44477405 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29157228 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.23092951 |
| 8 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.21938997 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.15064191 |
| 10 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.07689520 |
| 11 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.02161007 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95335292 |
| 13 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.88556256 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87018585 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86483309 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82460974 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79933735 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79169503 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76945547 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76449221 |
| 21 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67255999 |
| 22 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.64845329 |
| 23 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59666372 |
| 24 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59666372 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58562145 |
| 26 | CJUN_26792858_Chip-Seq_BT549_Human | 1.55682359 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53324909 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51083256 |
| 29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.48302624 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46197787 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45179468 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.44853628 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44004930 |
| 34 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43479171 |
| 35 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43428064 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42408057 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36362646 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36207294 |
| 39 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35711584 |
| 40 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35711584 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34231989 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34148483 |
| 43 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33260600 |
| 44 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27428202 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27301509 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26582348 |
| 47 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25995827 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25835175 |
| 49 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25225504 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25082636 |
| 51 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24322284 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23296826 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22579237 |
| 54 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22414983 |
| 55 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22013945 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21882027 |
| 57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20435662 |
| 58 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20375351 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19355142 |
| 60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18932885 |
| 61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18041173 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18041173 |
| 63 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17235485 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16673105 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16124324 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16009033 |
| 67 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15612864 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15359813 |
| 69 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15296905 |
| 70 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15296905 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12906595 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12867440 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12684450 |
| 74 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12537368 |
| 75 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12237291 |
| 76 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11701600 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10945017 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09236336 |
| 79 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08828041 |
| 80 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08768780 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08300346 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07537887 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07039040 |
| 84 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06547689 |
| 85 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06233326 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05746540 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05654062 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04980204 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04731346 |
| 90 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03113261 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02445280 |
| 92 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.02181081 |
| 93 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02161489 |
| 94 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01938862 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01192603 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99433679 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98968413 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98775587 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98710994 |
| 100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98244565 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98050354 |
| 102 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97386678 |
| 103 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97248966 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96001373 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95755658 |
| 106 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95089953 |
| 107 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93562010 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92274074 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90812863 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90576538 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90478579 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90468701 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90128514 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89017530 |
| 115 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88676732 |
| 116 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87627770 |
| 117 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87588182 |
| 118 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87491867 |
| 119 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87451432 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86507418 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86409668 |
| 122 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86053969 |
| 123 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85099252 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84708183 |
| 125 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84517904 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84311029 |
| 127 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83788217 |
| 128 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83296056 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83028336 |
| 130 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82770568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.38592169 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.85007864 |
| 3 | MP0005360_urolithiasis | 3.60563381 |
| 4 | MP0005365_abnormal_bile_salt | 3.07515963 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.02638127 |
| 6 | MP0004272_abnormal_basement_membrane | 3.00286683 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.98335963 |
| 8 | MP0003252_abnormal_bile_duct | 2.92740860 |
| 9 | MP0003195_calcinosis | 2.55481312 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.45865173 |
| 11 | MP0009384_cardiac_valve_regurgitation | 2.44079069 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.43002494 |
| 13 | MP0006054_spinal_hemorrhage | 2.40385330 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.36059637 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.31188069 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.23487888 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17605628 |
| 18 | MP0005083_abnormal_biliary_tract | 2.12408399 |
| 19 | MP0005275_abnormal_skin_tensile | 2.11427357 |
| 20 | MP0003279_aneurysm | 1.90024821 |
| 21 | MP0001542_abnormal_bone_strength | 1.80486940 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.78009275 |
| 23 | MP0003045_fibrosis | 1.77570194 |
| 24 | MP0002295_abnormal_pulmonary_circulatio | 1.74517773 |
| 25 | MP0005023_abnormal_wound_healing | 1.73210780 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.67103985 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.65029618 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.64287301 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.60878873 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.58091851 |
| 31 | MP0003868_abnormal_feces_composition | 1.54476811 |
| 32 | MP0003941_abnormal_skin_development | 1.51696956 |
| 33 | MP0002168_other_aberrant_phenotype | 1.50684802 |
| 34 | MP0005408_hypopigmentation | 1.47831193 |
| 35 | MP0003828_pulmonary_edema | 1.41914530 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.40193340 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.39471243 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.37603500 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.36992917 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.33654427 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.32845966 |
| 42 | MP0001958_emphysema | 1.32162436 |
| 43 | MP0005332_abnormal_amino_acid | 1.31066983 |
| 44 | MP0006138_congestive_heart_failure | 1.29548659 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.28794959 |
| 46 | MP0005670_abnormal_white_adipose | 1.27810023 |
| 47 | MP0001299_abnormal_eye_distance/ | 1.25927499 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.25786366 |
| 49 | MP0004270_analgesia | 1.24911488 |
| 50 | MP0005171_absent_coat_pigmentation | 1.24249871 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.23870512 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.23136525 |
| 53 | MP0000751_myopathy | 1.22462103 |
| 54 | MP0004130_abnormal_muscle_cell | 1.19754659 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.18194266 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.17744702 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.17433084 |
| 58 | MP0000920_abnormal_myelination | 1.15675444 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.14900244 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.14302695 |
| 61 | MP0002249_abnormal_larynx_morphology | 1.14078796 |
| 62 | MP0005164_abnormal_response_to | 1.11794296 |
| 63 | MP0009250_abnormal_appendicular_skeleto | 1.10532819 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.08869718 |
| 65 | MP0005409_darkened_coat_color | 1.06024584 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.03896915 |
| 67 | MP0000749_muscle_degeneration | 1.02926781 |
| 68 | MP0000534_abnormal_ureter_morphology | 1.02186225 |
| 69 | MP0003283_abnormal_digestive_organ | 1.01727167 |
| 70 | MP0000762_abnormal_tongue_morphology | 1.00914642 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 0.99796007 |
| 72 | MP0005595_abnormal_vascular_smooth | 0.97812789 |
| 73 | MP0009840_abnormal_foam_cell | 0.97748271 |
| 74 | MP0001661_extended_life_span | 0.97482994 |
| 75 | MP0004883_abnormal_blood_vessel | 0.96423473 |
| 76 | MP0004084_abnormal_cardiac_muscle | 0.93962901 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.91820719 |
| 78 | MP0005395_other_phenotype | 0.91755395 |
| 79 | MP0000462_abnormal_digestive_system | 0.90513126 |
| 80 | MP0004036_abnormal_muscle_relaxation | 0.90222126 |
| 81 | MP0000579_abnormal_nail_morphology | 0.90070644 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.89881620 |
| 83 | MP0000609_abnormal_liver_physiology | 0.88496563 |
| 84 | MP0002928_abnormal_bile_duct | 0.88413523 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.88289477 |
| 86 | MP0002254_reproductive_system_inflammat | 0.88221790 |
| 87 | MP0002060_abnormal_skin_morphology | 0.87961833 |
| 88 | MP0005330_cardiomyopathy | 0.87268671 |
| 89 | MP0003385_abnormal_body_wall | 0.86881365 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.85967140 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.85580558 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.84397175 |
| 93 | MP0005451_abnormal_body_composition | 0.83577646 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.83253919 |
| 95 | MP0004043_abnormal_pH_regulation | 0.82590706 |
| 96 | MP0003091_abnormal_cell_migration | 0.82474920 |
| 97 | MP0000733_abnormal_muscle_development | 0.81621324 |
| 98 | MP0004510_myositis | 0.80703087 |
| 99 | MP0002971_abnormal_brown_adipose | 0.80636542 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.80165323 |
| 101 | MP0005369_muscle_phenotype | 0.79948881 |
| 102 | MP0005508_abnormal_skeleton_morphology | 0.79902815 |
| 103 | MP0004087_abnormal_muscle_fiber | 0.78324664 |
| 104 | MP0001614_abnormal_blood_vessel | 0.77610057 |
| 105 | MP0002269_muscular_atrophy | 0.77059782 |
| 106 | MP0001915_intracranial_hemorrhage | 0.76278559 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.76193722 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.74854407 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.74844425 |
| 110 | MP0004484_altered_response_of | 0.74646585 |
| 111 | MP0000678_abnormal_parathyroid_gland | 0.74498971 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.74107842 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.73848827 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.73811040 |
| 115 | MP0004233_abnormal_muscle_weight | 0.73040829 |
| 116 | MP0003690_abnormal_glial_cell | 0.72968210 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.72688163 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.72285570 |
| 119 | MP0002133_abnormal_respiratory_system | 0.72166054 |
| 120 | MP0005388_respiratory_system_phenotype | 0.72166054 |
| 121 | MP0003329_amyloid_beta_deposits | 0.71437803 |
| 122 | MP0001188_hyperpigmentation | 0.71109426 |
| 123 | MP0000747_muscle_weakness | 0.69748713 |
| 124 | MP0008004_abnormal_stomach_pH | 0.69691163 |
| 125 | MP0005165_increased_susceptibility_to | 0.69260052 |
| 126 | MP0001243_abnormal_dermal_layer | 0.68748938 |
| 127 | MP0002933_joint_inflammation | 0.68534631 |
| 128 | MP0010030_abnormal_orbit_morphology | 0.68017941 |
| 129 | MP0002128_abnormal_blood_circulation | 0.66729552 |
| 130 | MP0002106_abnormal_muscle_physiology | 0.66495085 |
| 131 | MP0003942_abnormal_urinary_system | 0.66322006 |
| 132 | MP0002127_abnormal_cardiovascular_syste | 0.65792568 |
| 133 | MP0000163_abnormal_cartilage_morphology | 0.65405025 |
| 134 | MP0001756_abnormal_urination | 0.63926656 |
| 135 | MP0000249_abnormal_blood_vessel | 0.63113957 |
| 136 | MP0002925_abnormal_cardiovascular_devel | 0.63026383 |
| 137 | MP0002115_abnormal_skeleton_extremities | 0.62540820 |
| 138 | MP0003755_abnormal_palate_morphology | 0.62123075 |
| 139 | MP0003935_abnormal_craniofacial_develop | 0.62077624 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.61167607 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.59659161 |
| 142 | MP0001544_abnormal_cardiovascular_syste | 0.59659161 |
| 143 | MP0000343_altered_response_to | 0.59465250 |
| 144 | MP0004858_abnormal_nervous_system | 0.58270757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.84493390 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.42728334 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.94167887 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.70723922 |
| 5 | Hypoglycemic coma (HP:0001325) | 3.62023683 |
| 6 | Xanthomatosis (HP:0000991) | 3.42948005 |
| 7 | Popliteal pterygium (HP:0009756) | 3.34043373 |
| 8 | Hypoalphalipoproteinemia (HP:0003233) | 3.09823316 |
| 9 | Protrusio acetabuli (HP:0003179) | 2.95221622 |
| 10 | Ulnar claw (HP:0001178) | 2.90348155 |
| 11 | Hyperglycemia (HP:0003074) | 2.89477463 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 2.88109724 |
| 13 | Round ear (HP:0100830) | 2.84478679 |
| 14 | Broad metatarsal (HP:0001783) | 2.84359204 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 2.83902091 |
| 16 | Hypoglycemic seizures (HP:0002173) | 2.77611606 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 2.77099890 |
| 18 | Complement deficiency (HP:0004431) | 2.76278966 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.75433902 |
| 20 | Neonatal short-limb short stature (HP:0008921) | 2.72045358 |
| 21 | Cervical subluxation (HP:0003308) | 2.71894741 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69716705 |
| 23 | Increased connective tissue (HP:0009025) | 2.61970374 |
| 24 | Abnormality of the ischium (HP:0003174) | 2.61558110 |
| 25 | Muscle fiber splitting (HP:0003555) | 2.54856133 |
| 26 | Atrophic scars (HP:0001075) | 2.54376275 |
| 27 | Spondylolisthesis (HP:0003302) | 2.53243167 |
| 28 | Ketosis (HP:0001946) | 2.51652014 |
| 29 | Osteolytic defects of the hand bones (HP:0009699) | 2.51340019 |
| 30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51340019 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.51318889 |
| 32 | Hypoplasia of the iris (HP:0007676) | 2.50802547 |
| 33 | Dilatation of the ascending aorta (HP:0005111) | 2.47094176 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.46342116 |
| 35 | Ketoacidosis (HP:0001993) | 2.46029692 |
| 36 | Aortic regurgitation (HP:0001659) | 2.45567942 |
| 37 | Fat malabsorption (HP:0002630) | 2.44054653 |
| 38 | Aortic dissection (HP:0002647) | 2.42131963 |
| 39 | Skin nodule (HP:0200036) | 2.41528067 |
| 40 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.40595237 |
| 41 | Aplasia of the musculature (HP:0100854) | 2.39919871 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.39768851 |
| 43 | Hyporeflexia of lower limbs (HP:0002600) | 2.38352906 |
| 44 | Hypoplastic ischia (HP:0003175) | 2.36463295 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.35590478 |
| 46 | Cardiovascular calcification (HP:0011915) | 2.35260325 |
| 47 | Abnormality of dentin (HP:0010299) | 2.35051400 |
| 48 | Spinal rigidity (HP:0003306) | 2.33403353 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.31818251 |
| 50 | Limited hip movement (HP:0008800) | 2.30668844 |
| 51 | Myocardial infarction (HP:0001658) | 2.27411750 |
| 52 | Insidious onset (HP:0003587) | 2.23521950 |
| 53 | Termporal pattern (HP:0011008) | 2.23521950 |
| 54 | Infantile muscular hypotonia (HP:0008947) | 2.20804769 |
| 55 | Turricephaly (HP:0000262) | 2.19842879 |
| 56 | Scapular winging (HP:0003691) | 2.15499875 |
| 57 | Onion bulb formation (HP:0003383) | 2.15192534 |
| 58 | Epidermoid cyst (HP:0200040) | 2.14592424 |
| 59 | Gowers sign (HP:0003391) | 2.12513447 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12187103 |
| 61 | Aneurysm (HP:0002617) | 2.10663276 |
| 62 | Aortic aneurysm (HP:0004942) | 2.09632293 |
| 63 | Ankle contracture (HP:0006466) | 2.09328987 |
| 64 | Aortic valve stenosis (HP:0001650) | 2.06716546 |
| 65 | Mitral valve prolapse (HP:0001634) | 2.05911246 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05823582 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.05273379 |
| 68 | Knee flexion contracture (HP:0006380) | 2.04047121 |
| 69 | Wide anterior fontanel (HP:0000260) | 2.03972940 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.03707287 |
| 71 | Cerebral aneurysm (HP:0004944) | 2.03351050 |
| 72 | Shallow orbits (HP:0000586) | 2.03080906 |
| 73 | Difficulty running (HP:0009046) | 2.02748604 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00576106 |
| 75 | Abnormality of complement system (HP:0005339) | 1.98195222 |
| 76 | Genu recurvatum (HP:0002816) | 1.97400219 |
| 77 | Natal tooth (HP:0000695) | 1.97282957 |
| 78 | Neurofibrillary tangles (HP:0002185) | 1.97226941 |
| 79 | Bradycardia (HP:0001662) | 1.97088245 |
| 80 | Coronal craniosynostosis (HP:0004440) | 1.95915109 |
| 81 | Wrist flexion contracture (HP:0001239) | 1.95540856 |
| 82 | Generalized amyotrophy (HP:0003700) | 1.94918278 |
| 83 | Mitral regurgitation (HP:0001653) | 1.94833901 |
| 84 | Sudden death (HP:0001699) | 1.93254790 |
| 85 | Elbow flexion contracture (HP:0002987) | 1.93013935 |
| 86 | Amniotic constriction ring (HP:0009775) | 1.92685954 |
| 87 | Abnormality of placental membranes (HP:0011409) | 1.92685954 |
| 88 | Hammertoe (HP:0001765) | 1.92679213 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92538486 |
| 90 | Hip contracture (HP:0003273) | 1.91937537 |
| 91 | Peritonitis (HP:0002586) | 1.91176774 |
| 92 | Striae distensae (HP:0001065) | 1.91037892 |
| 93 | Ectopia lentis (HP:0001083) | 1.90515540 |
| 94 | Potter facies (HP:0002009) | 1.90355751 |
| 95 | Facial shape deformation (HP:0011334) | 1.90355751 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 1.88761713 |
| 97 | Joint laxity (HP:0001388) | 1.88417542 |
| 98 | Vascular tortuosity (HP:0004948) | 1.88386562 |
| 99 | Slender build (HP:0001533) | 1.88365317 |
| 100 | Pterygium (HP:0001059) | 1.88150464 |
| 101 | Glucose intolerance (HP:0000833) | 1.87898113 |
| 102 | Action tremor (HP:0002345) | 1.87691861 |
| 103 | Hyperammonemia (HP:0001987) | 1.87195879 |
| 104 | Hyperextensible skin (HP:0000974) | 1.87168537 |
| 105 | Abnormal delivery (HP:0001787) | 1.87035123 |
| 106 | Fragile skin (HP:0001030) | 1.86186437 |
| 107 | Atrial fibrillation (HP:0005110) | 1.85480018 |
| 108 | Joint stiffness (HP:0001387) | 1.84932963 |
| 109 | Buphthalmos (HP:0000557) | 1.83755853 |
| 110 | Abnormal cartilage morphology (HP:0002763) | 1.83652236 |
| 111 | Symptomatic seizures (HP:0011145) | 1.83412737 |
| 112 | Camptodactyly of toe (HP:0001836) | 1.82867110 |
| 113 | Increased variability in muscle fiber diameter (HP:0003557) | 1.82347019 |
| 114 | Lipoatrophy (HP:0100578) | 1.82160500 |
| 115 | Short nail (HP:0001799) | 1.82082424 |
| 116 | Fetal akinesia sequence (HP:0001989) | 1.81462790 |
| 117 | Abnormality of the calf musculature (HP:0001430) | 1.81033166 |
| 118 | Pulmonary artery stenosis (HP:0004415) | 1.80974684 |
| 119 | Soft skin (HP:0000977) | 1.80740997 |
| 120 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80734884 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.80475430 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 1.79983732 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79983732 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79983732 |
| 125 | Polycythemia (HP:0001901) | 1.79950769 |
| 126 | Hypobetalipoproteinemia (HP:0003563) | 1.79776848 |
| 127 | Abnormality of the acetabulum (HP:0003170) | 1.77265109 |
| 128 | Bowel diverticulosis (HP:0005222) | 1.76189860 |
| 129 | Nonimmune hydrops fetalis (HP:0001790) | 1.74845465 |
| 130 | Bundle branch block (HP:0011710) | 1.74791974 |
| 131 | Insulin resistance (HP:0000855) | 1.74747828 |
| 132 | Distal upper limb amyotrophy (HP:0007149) | 1.74340189 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.74340189 |
| 134 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.73652766 |
| 135 | Mitral stenosis (HP:0001718) | 1.73432778 |
| 136 | Ovoid vertebral bodies (HP:0003300) | 1.73255409 |
| 137 | Limb-girdle muscle atrophy (HP:0003797) | 1.73159278 |
| 138 | Nemaline bodies (HP:0003798) | 1.73013615 |
| 139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72467855 |
| 140 | Overgrowth (HP:0001548) | 1.72433624 |
| 141 | Right ventricular cardiomyopathy (HP:0011663) | 1.70791914 |
| 142 | Hypercholesterolemia (HP:0003124) | 1.70374883 |
| 143 | Blue sclerae (HP:0000592) | 1.70159443 |
| 144 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69737882 |
| 145 | Distal arthrogryposis (HP:0005684) | 1.69467457 |
| 146 | Abnormality of glycine metabolism (HP:0010895) | 1.69284274 |
| 147 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.69284274 |
| 148 | Venous abnormality (HP:0002624) | 1.68998223 |
| 149 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68152342 |
| 150 | Fatigable weakness (HP:0003473) | 1.68152342 |
| 151 | Vascular calcification (HP:0004934) | 1.68151546 |
| 152 | Abnormality of the anterior chamber (HP:0000593) | 1.67621083 |
| 153 | Wormian bones (HP:0002645) | 1.67297357 |
| 154 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.67108421 |
| 155 | Arterial tortuosity (HP:0005116) | 1.65963196 |
| 156 | Esophageal varix (HP:0002040) | 1.65711588 |
| 157 | Venous insufficiency (HP:0005293) | 1.65348278 |
| 158 | Bladder diverticulum (HP:0000015) | 1.65304295 |
| 159 | Pancreatitis (HP:0001733) | 1.63567137 |
| 160 | Cerebral hemorrhage (HP:0001342) | 1.63354618 |
| 161 | Thin ribs (HP:0000883) | 1.62640844 |
| 162 | Type 1 muscle fiber predominance (HP:0003803) | 1.62131271 |
| 163 | Acanthosis nigricans (HP:0000956) | 1.62091621 |
| 164 | Mucopolysacchariduria (HP:0008155) | 1.61256234 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61256234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 2.96493078 |
| 2 | RIPK1 | 2.82398595 |
| 3 | SIK1 | 2.71781966 |
| 4 | INSRR | 2.71261748 |
| 5 | TIE1 | 2.68904103 |
| 6 | BCKDK | 2.60632103 |
| 7 | EPHB1 | 2.52011968 |
| 8 | TRIB3 | 2.25873816 |
| 9 | FGFR4 | 2.22326165 |
| 10 | PDGFRA | 2.09371122 |
| 11 | MET | 2.09028667 |
| 12 | EPHA3 | 2.08287815 |
| 13 | WNK4 | 2.08171831 |
| 14 | TTN | 1.93774578 |
| 15 | MUSK | 1.91889576 |
| 16 | DDR2 | 1.84648411 |
| 17 | PAK3 | 1.75907909 |
| 18 | EPHB2 | 1.69006396 |
| 19 | ERBB4 | 1.68361547 |
| 20 | NTRK1 | 1.61149461 |
| 21 | TAOK3 | 1.60623104 |
| 22 | STK39 | 1.54968724 |
| 23 | FGFR2 | 1.51892188 |
| 24 | PTK2 | 1.40453338 |
| 25 | FER | 1.31454594 |
| 26 | RET | 1.31192594 |
| 27 | LATS2 | 1.30824547 |
| 28 | ERN1 | 1.28308772 |
| 29 | MOS | 1.27625146 |
| 30 | PRKD3 | 1.27496097 |
| 31 | TESK1 | 1.26341423 |
| 32 | WNK1 | 1.24752125 |
| 33 | STK38 | 1.24237502 |
| 34 | MAP3K9 | 1.19826306 |
| 35 | PDGFRB | 1.19277959 |
| 36 | ERBB2 | 1.16627608 |
| 37 | MAP3K2 | 1.14240915 |
| 38 | FRK | 1.09291668 |
| 39 | KSR2 | 1.05810410 |
| 40 | STK38L | 1.04302639 |
| 41 | PTK6 | 1.03444105 |
| 42 | TGFBR2 | 1.03232889 |
| 43 | MAP3K3 | 1.00078606 |
| 44 | MAPK15 | 0.99686878 |
| 45 | PIK3CA | 0.99364701 |
| 46 | PRKAA2 | 0.96926790 |
| 47 | LMTK2 | 0.95226903 |
| 48 | ARAF | 0.94186246 |
| 49 | MAPK7 | 0.91898382 |
| 50 | PAK4 | 0.91448067 |
| 51 | PTK2B | 0.91068953 |
| 52 | CAMK1D | 0.90638221 |
| 53 | MAP2K1 | 0.90416105 |
| 54 | ROCK1 | 0.89044261 |
| 55 | PRKCH | 0.88243021 |
| 56 | MAP3K12 | 0.86485000 |
| 57 | DMPK | 0.86257019 |
| 58 | TRPM7 | 0.86084616 |
| 59 | PRKD1 | 0.86057392 |
| 60 | MARK2 | 0.85562868 |
| 61 | STK3 | 0.82403031 |
| 62 | EPHA2 | 0.82100878 |
| 63 | PAK6 | 0.81642873 |
| 64 | MST1R | 0.80392104 |
| 65 | KDR | 0.80250937 |
| 66 | SGK494 | 0.79839380 |
| 67 | SGK223 | 0.79839380 |
| 68 | MARK1 | 0.78588381 |
| 69 | DAPK3 | 0.78381087 |
| 70 | CAMK1G | 0.78073000 |
| 71 | MTOR | 0.75987752 |
| 72 | CDC42BPA | 0.75209008 |
| 73 | GSK3A | 0.74965070 |
| 74 | PKN1 | 0.74662257 |
| 75 | MAP3K13 | 0.74286410 |
| 76 | PAK2 | 0.73732573 |
| 77 | MELK | 0.72751327 |
| 78 | PRKCE | 0.71778892 |
| 79 | PKN2 | 0.71321212 |
| 80 | AKT3 | 0.70987115 |
| 81 | PNCK | 0.70007223 |
| 82 | MAPKAPK3 | 0.69736628 |
| 83 | NEK9 | 0.69686674 |
| 84 | PRKAA1 | 0.68854696 |
| 85 | RPS6KA2 | 0.68706413 |
| 86 | TYRO3 | 0.67727502 |
| 87 | OBSCN | 0.66607385 |
| 88 | PRKD2 | 0.64560104 |
| 89 | ROCK2 | 0.63849115 |
| 90 | JAK1 | 0.63117363 |
| 91 | CAMK2D | 0.62520922 |
| 92 | MAP3K1 | 0.62321866 |
| 93 | PHKG2 | 0.60089240 |
| 94 | PHKG1 | 0.60089240 |
| 95 | LIMK1 | 0.60000539 |
| 96 | ILK | 0.59355731 |
| 97 | ABL2 | 0.59312753 |
| 98 | PINK1 | 0.58863251 |
| 99 | NLK | 0.58667692 |
| 100 | IRAK1 | 0.57340548 |
| 101 | MAP3K6 | 0.56451689 |
| 102 | ICK | 0.52991811 |
| 103 | MYLK | 0.52331882 |
| 104 | CSNK1A1L | 0.52224928 |
| 105 | PIK3CG | 0.51917047 |
| 106 | FGFR3 | 0.50658918 |
| 107 | IGF1R | 0.50014239 |
| 108 | MAP2K2 | 0.49893843 |
| 109 | CSNK1G1 | 0.49483013 |
| 110 | CAMK2B | 0.49250382 |
| 111 | OXSR1 | 0.49238979 |
| 112 | CAMK2A | 0.49059454 |
| 113 | MAP3K7 | 0.48403495 |
| 114 | NEK6 | 0.48191457 |
| 115 | BCR | 0.48156322 |
| 116 | CDK9 | 0.47373932 |
| 117 | DAPK2 | 0.46238661 |
| 118 | INSR | 0.46067615 |
| 119 | CAMK2G | 0.44217408 |
| 120 | ADRBK1 | 0.42548114 |
| 121 | GRK5 | 0.42136781 |
| 122 | KSR1 | 0.42033019 |
| 123 | MAPK12 | 0.41951407 |
| 124 | TGFBR1 | 0.40728876 |
| 125 | PRKG2 | 0.40695446 |
| 126 | SGK3 | 0.40613989 |
| 127 | CDK8 | 0.39482959 |
| 128 | GRK1 | 0.39472067 |
| 129 | IRAK3 | 0.38939816 |
| 130 | PDPK1 | 0.36893433 |
| 131 | AKT2 | 0.36216526 |
| 132 | CCNB1 | 0.36026946 |
| 133 | MAPKAPK5 | 0.35845679 |
| 134 | NTRK3 | 0.35468952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13651196 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.88722210 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.56022037 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31823833 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16402119 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16222639 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.12189294 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99087220 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97652223 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93602415 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91667669 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89006005 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.87299030 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86773996 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84792464 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76929174 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71221874 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64547969 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60224889 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55632856 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54388839 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53328414 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.46250588 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.45486590 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.42250637 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41362410 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40521713 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40258819 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.39565642 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34257481 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32999761 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30527397 |
| 33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.30508394 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28430700 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.22971552 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.21844784 |
| 37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17095212 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16641094 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.14448354 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14383578 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11185272 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10116236 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08667384 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08337124 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.06448631 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04992520 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98945457 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98272447 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98230748 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96916206 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96909027 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95955638 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94710136 |
| 54 | Melanoma_Homo sapiens_hsa05218 | 0.94363053 |
| 55 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93937940 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93697938 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92286738 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92161771 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90692149 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89997766 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.89344470 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88928314 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88781965 |
| 64 | Protein export_Homo sapiens_hsa03060 | 0.88469952 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87236793 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86931002 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.86893218 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.85658629 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84782817 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84773014 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83865789 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83808312 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.83762675 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83750682 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83095089 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83073223 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82614007 |
| 78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82221515 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.81728522 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81721571 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.81003573 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80933807 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80234976 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.80220721 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79894100 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79630314 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79044504 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.78767471 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77891688 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76590085 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.76297411 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76225992 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74924647 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72771001 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71626947 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70469304 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70232909 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68373778 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.68160690 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68084672 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67761715 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.65585716 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65549995 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65468883 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64034507 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.63512716 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61413862 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60951576 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60703484 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60343760 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59178332 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58425785 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.58001995 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55814457 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55310062 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.55045392 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54771667 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53760191 |
| 119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52753813 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52510251 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51577041 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51376574 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50358177 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50036746 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.49158292 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.49068878 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48804862 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48462508 |
| 129 | Axon guidance_Homo sapiens_hsa04360 | 0.47416523 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.46922107 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46562472 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46404430 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45822987 |
| 134 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.45236465 |
| 135 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44927981 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44410185 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44381160 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43755595 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43669660 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43200058 |
| 141 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43085319 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.41979941 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40503158 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38806077 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36691127 |
| 146 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34747540 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33615323 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33236725 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33009610 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30700615 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29422755 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27329055 |
| 153 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26759572 |
| 154 | Gap junction_Homo sapiens_hsa04540 | 0.26296267 |
| 155 | Prostate cancer_Homo sapiens_hsa05215 | 0.26155392 |

